|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 100, 546-551, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
J Lavee, N Naveh, I Dinbar, A Shinfeld and DA Goor
Increased mean arterial pressure during the aortic crossclamp period while
on cardiopulmonary bypass was usually treated by us with hypotensive drugs.
We noticed, however, that aspirating shed excess pulmonary venous blood
from the open pleural cavities causes an immediate reduction in mean
arterial pressure, obviating the need for any further pharmaceutical
intervention. In this study we investigated the relationship between the
reduction in mean arterial pressure and the levels of prostacyclin and
prostaglandin E2 in the peripheral and pulmonary venous blood. Ten men
undergoing coronary bypass operations had 21 episodes of increased mean
arterial pressure (106.9 +/- 11.4 mm Hg) during aortic crossclamping, which
was reduced to 67.4 +/- 11.4 mm Hg (p less than 0.001) only by aspirating a
mean of 490 ml (range 150 to 1100 ml) of pulmonary venous blood from the
pleurae back into the circulation. Mean peripheral prostacyclin level,
measured as 6-keto- prostaglandin F1 alpha, and prostaglandin E2 level,
both measured by radioimmunoassay technique, were significantly lower at
peak mean arterial pressure (419 +/- 180 and 59.5 +/- 21.2 pg/ml) than at
lowest mean arterial pressure (632 +/- 271 and 96.7 +/- 52.4 pg/ml for
6-keto- prostaglandin F1 alpha and prostaglandin E2, respectively; p less
than 0.001). Prostaglandin F1 alpha and prostaglandin E2 levels in the
aspirated pulmonary venous blood were 2309 +/- 3098 pg/ml and 749 +/- 909
pg/ml, respectively. The hypotensive effect of shed pulmonary venous blood
that is aspirated back from the pleurae into the circulation seems to be
mediated by the high levels of prostacyclin and prostaglandin E2, both
powerful vasodilators.
ARTICLES
Prostacyclin and prostaglandin E2 mediate reduction of increased mean arterial pressure during cardiopulmonary bypass by aspiration of shed pulmonary venous blood
Department of Cardiac Surgery, Chaim Sheba Medical Center, Tel Hashomer, Israel.
This article has been cited by other articles:
![]() |
A. Castiglioni, A. Verzini, F. Pappalardo, N. Colangelo, L. Torracca, A. Zangrillo, and O. Alfieri Minimally Invasive Closed Circuit Versus Standard Extracorporeal Circulation for Aortic Valve Replacement Ann. Thorac. Surg., February 1, 2007; 83(2): 586 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Albes, I. M. Stohr, M. Kaluza, A. Siegemund, D. Schmidt, R. Vollandt, and T. Wahlers Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1504 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. De Somer, Y. Van Belleghem, F. Caes, K. Francois, H. Van Overbeke, J. Arnout, Y. Taeymans, and G. Van Nooten Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 951 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F Baugh Platelets and whole blood coagulation Perfusion, January 1, 2000; 15(1): 41 - 50. [Abstract] [PDF] |
||||
![]() |
H. P. Singh, E. T. Coleman, M. Hargrove, S. E. Barrow, M. B. Murphy, and T. Aherne Prostacyclin and Thromboxane Levels in Pleural Space Fluid During Cardiopulmonary Bypass Ann. Thorac. Surg., March 1, 1995; 59(3): 647 - 650. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |